cbdMD, Inc. (YCBD) Financials

YCBD Assets vs Liabilities

DateAssetsLiabilities
2023-12-31 15.1 million 8.1 million
2023-09-30 16.2 million 7.2 million
2023-06-30 33.0 million 7.2 million
2023-03-31 33.7 million 7.9 million

YCBD Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-12-31 -297020 1.8 million
2023-09-30 -383681 106888
2023-06-30 -342962 39515
2023-03-31 -1.6 million 73570

YCBD Net Income

No data available :(

YCBD Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-12-31 1.5 million - 3.4 million
2023-09-30 1.8 million - 3.7 million
2023-06-30 2.8 million - 4.0 million
2023-03-31 1.7 million - 4.3 million

YCBD Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-12-31 3.0 million
2023-09-30 2.0 million
2023-06-30 1.0 million
2023-03-31 2.4 million

YCBD Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-12-31 184635 4629 1.9 million 1.4 million
2023-09-30 120180 16039 942872 1.8 million
2023-06-30 102389 24566 2.3 million 1.9 million
2023-03-31 102390 56161 2.6 million 1.3 million

YCBD Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-12-31 5.4 million 2.1 million
2023-09-30 5.7 million 2.2 million
2023-06-30 6.1 million 2.3 million
2023-03-31 6.2 million 2.2 million

YCBD

Price: $0.89

52 week price:
0.56
8.55

Earnings Per Share: -10.29 USD

P/E Ratio: -0.06

Exchange: ASE

Sector: Healthcare

Industry: Drug Manufacturers - Specialty & Generic

Volume: 457300

Market Capitalization: 2.7 million

Links: